- 90.1k views
Cardiac arrest and its management in emergency
In recent years, significant advances have been made in the treatment of rheumatoid arthritis (RA), a chronic autoimmune disease that primarily affects the joints. These advancements have revolutionized the management of RA, providing new hope and improved outcomes for patients. Biologic drugs have emerged as a game-changer in RA treatment. These medications specifically target molecules and pathways involved in the immune response, such as tumor necrosis factor (TNF), interleukin-6 (IL-6), and Janus kinase (JAK) enzymes. Biologics have shown remarkable efficacy in reducing inflammation, slowing disease progression, and improving overall joint function. The concept of personalized medicine has gained prominence in RA treatment. Genetic testing and biomarker analysis help identify specific characteristics and disease mechanisms in individual patients. This information enables physicians to tailor treatment strategies, selecting the most appropriate medications and dosages for each person, leading to better outcomes. In cases where joint damage is severe and non-responsive to medical therapy, surgical interventions have also seen advancements. Joint replacement surgeries, such as total hip or knee replacements, have become increasingly sophisticated and durable, relieving pain and restoring mobility for individuals with advanced RA.
About the Speaker
Dr.Vishant Sharma
Medical officer, Dept of Emergency, Civil Hospital District Shimla, Dept of Health and family welfare, Himachal Pradesh
Dr Vishant sharma completed his MBBS from rajiv gandhi university bangalore. Diploma in community mental health , nimhans bangalore . Dept of health and family welfare for himachal pradesh for 5 years. Masters in emergency medicine and trauma USA. Currently working in max super speciality hospital gurgaon Haryana.
Upcoming Case Discussions
Scale Healthcare Brands with AI-Powered Marketing
The AI revolution in medicine is transforming healthcare, making it smarter and more efficient than ever before. From early disease detection to personalized treatment plans, AI empowers doctors with data-driven insights for better decision-making. Robotic surgeries and AI-assisted diagnostics are enhancing precision and reducing human error. AI also improves patient care through virtual assistants and remote monitoring tools. This technological leap is paving the way for a future where healthcare is more accessible, accurate, and innovative.
Comprehensive Approaches to Pediatric Practice
Comprehensive approaches to pediatric practice emphasize holistic care that integrates early screening, preventive measures, and tailored treatments. These strategies involve using tools like the NISA card for early detection of conditions such as iron deficiency anemia. Regular anthropometric assessments provide insight into growth and development, allowing for early intervention. Incorporating neurodevelopmental screening tools ensures that cognitive, emotional, and physical milestones are monitored effectively. Collaborative care models, including parental involvement and education, support continuous patient engagement. Digital health tools can enhance monitoring and streamline consultations. Multidisciplinary teams can address complex cases more efficiently. Preventive care and health education are prioritized to reduce long-term risks. Comprehensive approaches foster a proactive environment that adapts to each child's needs. The result is improved health outcomes and overall child well-being.
Case Based Discussion on Bronchiolitis
Bronchiolitis is a common respiratory infection in infants and young children, primarily caused by the respiratory syncytial virus (RSV). It presents with nasal congestion, cough, wheezing, and difficulty breathing, often following an upper respiratory infection. Management is largely supportive, focusing on hydration, oxygen therapy, and suctioning nasal secretions. Routine use of bronchodilators, steroids, or antibiotics is not recommended. Severe cases may require hospitalization for respiratory support, such as high-flow nasal cannula or mechanical ventilation. Preventive measures include proper hand hygiene and, in high-risk infants, palivizumab prophylaxis. Prompt recognition and appropriate care are key to reducing complications and improving outcomes.
Diabetic Complications in 12 Questions
Diabetic complications in 12 Questions" is designed to address common concerns related to the long-term effects of diabetes, such as neuropathy, retinopathy, and cardiovascular issues. Through a Q&A format, the session aims to educate participants on prevention, early detection, and management strategies for these complications to improve overall diabetic care.
Management of ICU Delirium
The management of ICU delirium involves a combination of preventive strategies, such as early mobilization, minimizing sedation, and addressing underlying medical causes, to reduce the risk and severity of delirium in critically ill patients. Treatment includes optimizing the patient's environment, using non-pharmacological interventions, and, if necessary, medications to manage symptoms while focusing on long-term cognitive recovery.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr.Vishant Sharma 's Talks on Assimilate
- 11th-December-2023, TIME : 06:00PM - 07:00PM
- 0
In recent years, significant advances have been made in the treatment of rheumatoid arthritis (RA), a chronic autoimmune disease that primarily affects the joints. These advancements have revolutionized the management of RA, providing new hope and improved outcomes for patients. Biologic drugs have emerged as a game-changer in RA treatment. These medications specifically target molecules and pathways involved in the immune response, such as tumor necrosis factor (TNF), interleukin-6 (IL-6), and Janus kinase (JAK) enzymes. Biologics have shown remarkable efficacy in reducing inflammation, slowing disease progression, and improving overall joint function. The concept of personalized medicine has gained prominence in RA treatment. Genetic testing and biomarker analysis help identify specific characteristics and disease mechanisms in individual patients. This information enables physicians to tailor treatment strategies, selecting the most appropriate medications and dosages for each person, leading to better outcomes. In cases where joint damage is severe and non-responsive to medical therapy, surgical interventions have also seen advancements. Joint replacement surgeries, such as total hip or knee replacements, have become increasingly sophisticated and durable, relieving pain and restoring mobility for individuals with advanced RA.
- 11th-December-2023, TIME : 06:00PM - 07:00PM
- 0
In recent years, significant advances have been made in the treatment of rheumatoid arthritis (RA), a chronic autoimmune disease that primarily affects the joints. These advancements have revolutionized the management of RA, providing new hope and improved outcomes for patients. Biologic drugs have emerged as a game-changer in RA treatment. These medications specifically target molecules and pathways involved in the immune response, such as tumor necrosis factor (TNF), interleukin-6 (IL-6), and Janus kinase (JAK) enzymes. Biologics have shown remarkable efficacy in reducing inflammation, slowing disease progression, and improving overall joint function. The concept of personalized medicine has gained prominence in RA treatment. Genetic testing and biomarker analysis help identify specific characteristics and disease mechanisms in individual patients. This information enables physicians to tailor treatment strategies, selecting the most appropriate medications and dosages for each person, leading to better outcomes. In cases where joint damage is severe and non-responsive to medical therapy, surgical interventions have also seen advancements. Joint replacement surgeries, such as total hip or knee replacements, have become increasingly sophisticated and durable, relieving pain and restoring mobility for individuals with advanced RA.
- 11th-December-2023, TIME : 06:00PM - 07:00PM
- 0
In recent years, significant advances have been made in the treatment of rheumatoid arthritis (RA), a chronic autoimmune disease that primarily affects the joints. These advancements have revolutionized the management of RA, providing new hope and improved outcomes for patients. Biologic drugs have emerged as a game-changer in RA treatment. These medications specifically target molecules and pathways involved in the immune response, such as tumor necrosis factor (TNF), interleukin-6 (IL-6), and Janus kinase (JAK) enzymes. Biologics have shown remarkable efficacy in reducing inflammation, slowing disease progression, and improving overall joint function. The concept of personalized medicine has gained prominence in RA treatment. Genetic testing and biomarker analysis help identify specific characteristics and disease mechanisms in individual patients. This information enables physicians to tailor treatment strategies, selecting the most appropriate medications and dosages for each person, leading to better outcomes. In cases where joint damage is severe and non-responsive to medical therapy, surgical interventions have also seen advancements. Joint replacement surgeries, such as total hip or knee replacements, have become increasingly sophisticated and durable, relieving pain and restoring mobility for individuals with advanced RA.